Latest market price
12.15
-0.71-5.52%
OverviewShort InterestFilings
KLRAQT13Kailera Therapeutics, Inc.·NASDAQ
12.15-5.52%

Latest SEC Filings

Form category
DescriptionFilingDocument
Sep 09, 20263Initial statement of beneficial ownership
Sep 09, 20264Statement of changes in beneficial ownership
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 14, 2026SC 13GBeneficial ownership statement (passive)
Aug 12, 20268-KCurrent report
Aug 12, 202610-QQuarterly report
Aug 05, 2026SC 13GBeneficial ownership statement (passive)
Jul 08, 20264Statement of changes in beneficial ownership
Jul 08, 20263Initial statement of beneficial ownership
Jun 11, 20264Statement of changes in beneficial ownership
May 26, 20268-KCurrent report
May 26, 202610-QQuarterly report
Apr 23, 2026SC 13DBeneficial ownership statement (active)
Apr 23, 2026SC 13DBeneficial ownership statement (active)
Apr 22, 20264Statement of changes in beneficial ownership
Apr 22, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
Apr 20, 20264Statement of changes in beneficial ownership
#1 / 25 of 62
Page
▼
/ 3